These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 31626293)
21. LRRK2 G2019S and Parkinson's disease: insight from Neuroinflammation. Yao XY; Guan LN; Chen Q; Ren C Postgrad Med J; 2023 Dec; 100(1179):4-11. PubMed ID: 37777187 [TBL] [Abstract][Full Text] [Related]
22. ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression. Zhu Y; Wang C; Yu M; Cui J; Liu L; Xu Z Protein Cell; 2013 Sep; 4(9):711-21. PubMed ID: 27023913 [TBL] [Abstract][Full Text] [Related]
24. LRRK2 impairs autophagy by mediating phosphorylation of leucyl-tRNA synthetase. Ho DH; Kim H; Nam D; Sim H; Kim J; Kim HG; Son I; Seol W Cell Biochem Funct; 2018 Dec; 36(8):431-442. PubMed ID: 30411383 [TBL] [Abstract][Full Text] [Related]
35. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749 [TBL] [Abstract][Full Text] [Related]
36. Tyrosine Metabolism Pathway Is Downregulated in Dopaminergic Neurons with LRRK2 Overexpression in Cheng J; Wu BT; Liu HP; Lin WY Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958569 [TBL] [Abstract][Full Text] [Related]
37. The C-Terminal Domain of LRRK2 with the G2019S Substitution Increases Mutant A53T α-Synuclein Toxicity in Dopaminergic Neurons In Vivo. Cresto N; Gardier C; Gaillard MC; Gubinelli F; Roost P; Molina D; Josephine C; Dufour N; Auregan G; Guillermier M; Bernier S; Jan C; Gipchtein P; Hantraye P; Chartier-Harlin MC; Bonvento G; Van Camp N; Taymans JM; Cambon K; Liot G; Bemelmans AP; Brouillet E Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201785 [TBL] [Abstract][Full Text] [Related]
38. GTP-binding inhibitors increase LRRK2-linked ubiquitination and Lewy body-like inclusions. Thomas JM; Wang X; Guo G; Li T; Dai B; Nucifora LG; Nucifora FC; Liu Z; Xue F; Liu C; Ross CA; Smith WW J Cell Physiol; 2020 Oct; 235(10):7309-7320. PubMed ID: 32180220 [TBL] [Abstract][Full Text] [Related]
39. Identification of Targets from LRRK2 Rescue Phenotypes. Toh J; Chua LL; Ho P; Sandanaraj E; Tang C; Wang H; Tan EK Cells; 2021 Jan; 10(1):. PubMed ID: 33466414 [TBL] [Abstract][Full Text] [Related]
40. Interferon-γ signaling synergizes with LRRK2 in neurons and microglia derived from human induced pluripotent stem cells. Panagiotakopoulou V; Ivanyuk D; De Cicco S; Haq W; Arsić A; Yu C; Messelodi D; Oldrati M; Schöndorf DC; Perez MJ; Cassatella RP; Jakobi M; Schneiderhan-Marra N; Gasser T; Nikić-Spiegel I; Deleidi M Nat Commun; 2020 Oct; 11(1):5163. PubMed ID: 33057020 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]